Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Diagnostics & Research

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs. The company was founded in 1949 and is based in Gurugram, India.

Revenue projections:

Revenue projections for LALPATHLAB
Revenue projections for LALPATHLAB

Revenues for LALPATHLAB are expected to drop compared to the previous year, which could be a cause for concern for investors. A decline in earnings may negatively impact the company's profitability, leading cautious investors to reconsider their positions, as it often signals challenges in overall financial health.

Financial Ratios:

currentRatio 3.389000
forwardPE 39.713123
debtToEquity 7.135000
earningsGrowth 0.832000
revenueGrowth 0.105000
grossMargins 0.578580
operatingMargins 0.229500
trailingEps 58.530000
forwardEps 29.380000

LALPATHLAB's current ratio is 3.389, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as LALPATHLAB should not face any issues meeting its short-term liabilities with available resources.
LALPATHLAB's positive earnings and revenue growth reflect an optimistic outlook for the company's future. The growth in these key areas indicates that LALPATHLAB is expected to continue expanding its business and boosting its financial performance in the coming periods.
Dr. Lal PathLabs Limited's positive gross and operating margins highlight its strong profitability. The company's ability to control costs while generating revenue indicates efficient operations and a healthy financial position.
Dr. Lal PathLabs Limited's forward EPS being lower than its trailing EPS suggests that the company is expected to see a decline in profitability. This signals that the company may face a challenging financial year ahead.

Price projections:

Price projections for LALPATHLAB
Price projections for LALPATHLAB

Over time, LALPATHLAB's price projections have been consistently revised lower. This suggests analysts are becoming less optimistic about the company's future prospects and are adjusting their forecasts accordingly.

Insider Transactions:

Insider Transactions for LALPATHLAB
Insider Transactions for LALPATHLAB


49 transactions to sell LALPATHLAB occurred, with market price at 3083.736726721939.There were no sell transactions during the period under consideration.LALPATHLAB's current price levels are seeing more buying activity than selling, which might indicate a bullish sentiment. Investors appear to be confident, interpreting the buying trend as a sign of positive expectations for the stock's future performance.

Recommendation changes over time:

Recommendations trend for LALPATHLAB
Recommendations trend for LALPATHLAB


A recent buy bias from analysts toward Dr. Lal PathLabs Limited indicates strong confidence in the stock's future performance. This could encourage investors to park their money in Dr. Lal PathLabs Limited, viewing it as a stable and potentially rewarding investment opportunity with promising long-term growth prospects.